These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9221571)

  • 1. [Clinical experience with changing type I diabetics from animal to human insulin administered by the NovoPen 3 applicator].
    Lacigová S; Perusicová J; Dohnalová L; Mertl J
    Vnitr Lek; 1997 Mar; 43(3):137-41. PubMed ID: 9221571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.
    Small M; MacRury S; Boal A; Paterson KR; MacCuish AC
    Diabetes Res; 1988 Jun; 8(2):85-9. PubMed ID: 3067951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-term and long-term effect of metformin in type 1 diabetics].
    Lacigová S; Rusavý Z; Kyselová P; Jankovec Z; Kárová R; Cechurová D
    Vnitr Lek; 2001 Feb; 47(2):81-6. PubMed ID: 15635851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with NovoPen II and insulin Protaphane HM Penfill.
    Kølendorf K; Beck-Nielsen H; Oxenbøll B
    Postgrad Med J; 1988; 64 Suppl 3():14-6; discussion 21. PubMed ID: 3074294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short-term hospitalization for patient education--effect on metabolic compensation in type I diabetics].
    Kvapil M
    Vnitr Lek; 1996 Jan; 42(1):12-6. PubMed ID: 8629352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of insulin loss in treatment of diabetics using the classical syringe or the insulin pen (Novopen II)].
    Krahulec B; Strbová L; Seböková E; Cárský J; Klimes I
    Vnitr Lek; 1996 Sep; 42(9):640-5. PubMed ID: 8984774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of purified insulins on insulin requirement and metabolic control.
    Yajnik VH; Vatsraj DJ; Vora LS; Patel SI; Kapur A
    J Assoc Physicians India; 1990 Apr; 38(4):281-2. PubMed ID: 2202711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of unstable diabetes mellitus in children and adolescents using insulin administered by a semi-automated syringe, NovoPen].
    Necić S; Nikezić M; Sajić S; Radmanović S
    Srp Arh Celok Lek; 1989; 117(7-8):453-8. PubMed ID: 2688138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between monocomponent human insulin U-40 and U-100 in CSII treatment of type 1 diabetics.
    Capani F; Carta Q; Vannini P; Ciaverella A; Consoli A; Fiocchi F; Monge L; Vitacolonna E; Sensi S
    Diabetes Res; 1986 Jul; 3(6):317-20. PubMed ID: 3530595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences with conversion from MC-insulin NOVO to L-insulin S.N.C. of insulin dependent diabetic patients].
    Hildebrandt R; Ziehe H; Ziehe S; Ratzmann KP
    Z Gesamte Inn Med; 1990 Aug; 45(15):460-3. PubMed ID: 2247996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin therapy using a new injection device. Experience with 36 type I diabetics].
    Stracke H; Federlin K
    Dtsch Med Wochenschr; 1987 Mar; 112(10):385-8. PubMed ID: 3545743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Compensation in diabetes and serum insulin levels in type I diabetics during insulin pump therapy and after changing to treatment with a combination of short- and long-acting insulin].
    Páv J; Svacina S; Srámková J; Hilgertová J
    Cas Lek Cesk; 1990 May; 129(19):596-601. PubMed ID: 2190689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitus.
    Garber AJ; Davidson JA; Krosnick A; Beaser RS; Anderson JH
    Clin Ther; 1991; 13(5):627-36. PubMed ID: 1799920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose accuracy of new versus used Novopen 4 insulin pens.
    Yucel H; Taks M; Menheere P; Grouls R; Bravenboer B
    Diabetes Technol Ther; 2012 Sep; 14(9):810-2. PubMed ID: 22866889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of insulin antibodies on insulin aspart pharmacokinetics and pharmacodynamics after 12-week treatment with multiple daily injections of biphasic insulin aspart 30 in patients with type 1 diabetes.
    Chen JW; Frystyk J; Lauritzen T; Christiansen JS
    Eur J Endocrinol; 2005 Dec; 153(6):907-13. PubMed ID: 16322398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.